The drug Gleevec (imatinib mesylate) is well known not only for its effectiveness against chronic myeloid leukemia (CML) and acute lymphoblastic leukemia, but also for the story behinds its development. The drug was specifically designed to target an abnormal molecule--a fusion of two normal cell proteins--that fueled a tumor's growth.
from The Medical News http://ift.tt/1KIfddJ
from The Medical News http://ift.tt/1KIfddJ
No comments:
Post a Comment